Corindus Vascular Robotics

Corindus Vascular Robotics (Corindus, Inc.) was founded in 2002 by Rafael Beyar, an interventional cardiologist, and Tal Wenderow. Its goal is to use remote control and robotics to move coronary guidewires and balloon/stent catheters.[1][2]

Corindus Vascular Robotics.
Corindus Vascular Robotics
Traded asAMEX: CVRS
Russell Microcap Index component
Headquarters
United States of America 

Corindus, Inc. is based in Waltham, Massachusetts. The company's FDA-cleared CorPath® System is the first medical device that allows interventional cardiologists to manipulate guidewires and balloon/stents from an interventional cockpit.[3]

The company went public in August 2014 and currently trades on the New York Stock Exchange with the ticker symbol CVRS.

In August 2019 Siemens Healthineers announced its intention to acquire Corindus Vascular Robotics for 1.1 billion US-Dollar.[4]

References
  1. "20/20 Healthcare Partners". Archived from the original on 2013-08-12. Retrieved 2013-06-11.
  2. "The United States Patent and Trademark Office".
  3. "How It Works". Corindus Vascular Robotics.
  4. "Siemens Healthineers plant Milliardenübernahme". Frankfurter Allgemeine Zeitung.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.